Obesity & Weight Management in the GLP-1 Era
Semaglutide and tirzepatide changed obesity care. For many patients, the question is no longer access to medication. It is whether the care surrounding it protects muscle mass, nutritional status, and long-term metabolic health. This course equips integrative clinicians to answer that question in practice.

Modules
Disordered Eating
Healthy Aging
Weight Management
Hormonal Health
Gut Health
Diet Decoder
Clinical Nutrition
How weight management has changed
Obesity care can no longer be reduced to "eat less and move more." Patients arrive curious about medication, already using it, experiencing side effects, losing muscle, or seeking alternatives. Integrative clinicians need a clear position; not ideological opposition or uncritical endorsement, but a responsible co-management framework
Modules
What you'll be able to do
Explain obesity through a modern biological and clinical framework, not a behavioural one alone.
Discuss semaglutide and tirzepatide with enough professional literacy to educate, refer, and co-manage — within scope.
Recognise when referral to a prescribing clinician is appropriate, and communicate effectively across care teams.
Support patients already using GLP-1 medications: nutrition, hydration, gastrointestinal tolerance, protein intake, and muscle preservation.
Identify sarcopenia risk during rapid weight loss and build a practical prevention plan.
Address hormonal, sleep, stress, and metabolic factors that GLP-1 medications do not resolve.
Evaluate intermittent fasting more carefully in weight-management patients.
Respond to patients seeking natural GLP-1 alternatives without hype or dismissal.
Use structured patient-scenario workflows for the six clinical presentations this course covers.
What's included
Prescribing-clinician communication templates
GLP-1 co-management checklists
Referral guides
Protein and sarcopenia-risk tools
Micronutrient checklists
Six patient scenario workflows covering curiosity through discontinuation.
Individual courses answer focused questions. The full track teaches you how those questions connect. A patient on a GLP-1 medication may also carry sarcopenia risk, gut symptoms, micronutrient gaps, and a disordered-eating pattern at the same time. Treating each in isolation misses the case. The value of the full track is seeing the whole picture.
Single course
Focused training in one area
One course of your choice
Course-specific resources
Certificate of completion for that course
Full track
A complete clinical nutrition framework
The integrative role
GLP-1 medications reduce appetite and support significant weight loss. They do not create a complete care plan. Patients still need support with protein adequacy, muscle preservation, micronutrient intake, digestive symptoms, sleep and stress physiology, insulin resistance, hormonal contributors, and long-term maintenance. Disordered eating risk is a consideration pharmacology does not address.
From weight-loss advice to clinical co-management
The course is built around six real-world patient presentations.
The GLP-1-curious patient
How to discuss expectations, referral, risks, benefits, nutritional preparation, and the role of lifestyle before medication begins.
The patient already on GLP-1 therapy
How to support nutrition, hydration, gastrointestinal tolerance, protein intake, micronutrient status, and muscle preservation.
The patient losing weight too quickly
How to identify risk patterns, screen for inadequate intake, and respond appropriately.
The non-responder
How to think through adherence, metabolic contributors, sleep, stress, medications, and when to refer.
The discontinuing patient
How to build maintenance supports before and after tapering or stopping medication.
The patient seeking natural alternatives
How to separate evidence-informed metabolic support from exaggerated supplement claims.

Who this course is for
Practitioners seeing patients with obesity, metabolic syndrome, type 2 diabetes, insulin resistance, PCOS, or NAFLD — and any clinician regularly asked about semaglutide, tirzepatide, or natural alternatives.
Relevant for naturopathic doctors, integrative medical doctors, dietitians, nutrition professionals, and allied health practitioners in primary-care-adjacent settings or those building a metabolic-health focus.



